01.06.2006 | Original Article
Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients
A phase 2 trial
Erschienen in: Medical Oncology | Ausgabe 2/2006
Einloggen, um Zugang zu erhalten